Beyond the abstract & Kinetica [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2015-02-11 15:27 (3352 d 09:28 ago) – Posting: # 14404
Views: 14,018

Hi ElMaestro,

❝ [humor]


❝   Because they used Kinetica :crying:

❝ [/humor]


Nope: “For the statistical analysis of data derived from this in vivo study; general parametric procedures for linear models (normal theory) were used and an analysis of variance (ANOVA) was performed using the statistical application Phoenix™ Win­Nonlin®; version 6.3; 2013.”

BTW (Dec 24 2014, source)…

Kinetica 5.1 SP1 has been released
Thermo Fisher Scientific is very pleased to announce the release of Kinetica 5.1 SP1. Kinetica now supports unbalanced data sets for two period, two treatments, two se­quences Bio­equi­va­lence studies. This issue was first reported in the Journal of the American Association of Pharma­ceutical Scientists (AAPS) article entitled, "Reference Datasets for 2-Treatment, 2-Sequence, 2-Period Bioequivalence Studies. The article described the validation of software used to assess bioequivalence and reported that results from Kinetica software differed from other similar software when un­ba­lanc­ed datasets were used (results for balanced datasets were consistent across all of the software packages). Please find the […] issues fixed below:
Issue Description
Incorrect equations used for bioequivalence determination in unbalanced datasets – Point Estimate and 90% Upper and Lower limit calculation
for Latin Square 2 For­mu­la­tions statistical analysis.

Do you expect that Thermo fixed the bug for parallel designs as well? I don’t.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,984 posts in 4,822 threads, 1,652 registered users;
51 visitors (0 registered, 51 guests [including 5 identified bots]).
Forum time: 01:56 CEST (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5